ghk-cu hair growth study human randomized Guide: Protocols & Results for Canadians Thermodynamically stable ionic liquid microemulsions

Cascade of events leading to liver injury in Wilson disease Different mechanistic steps, as summarized above [Table 1], ultimately result in liver injury in patients with Wilson disease [39-68]

Technical Specifications Compound: Glycyl-L-Histidyl-L-Lysine Copper Complex (GHK-Cu) Format: Lyophilized peptide powder Strength: 50 mg per vial Purity: 9899% (COA included) Appearance: Blue-tinted lyophilized powder Category: Research peptide reagent Intended Use This product is intended solely for: Laboratory experimentation Controlled in-vitro research Molecular and biochemical pathway studies Metal-peptide interaction research Non-human preclinical modeling Academic and institutional scientific projects Not intended for: Human or animal consumption Injection, ingestion, inhalation, topical, or cosmetic use Medical, therapeutic, or dermatological applications This material is not approved by Health Canada, FDA, or any regulatory body for clinical or cosmetic use

Lynch, G

GHK-Cu adds another layer of concern because FDA has specifically discussed immunogenicity risk for injectable GHK-Cu related to potential aggregation and peptide-related impurities

Free Metal pen worth 25 A reusable pen is added free to your order, automatically